GRI Bio, Inc.

GRI Bio, Inc.

GRI · Nasdaq

GRI Bio, Inc. (GRI) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for GRI Bio, Inc. in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 89 days

EPS estimate

-1.08

Revenue estimate

0

Past earnings

14 Aug 2026
EPS actual
—
estimate -1.20
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 May 2026
EPS actual
-1.61 (-0.3%)
estimate -1.61
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Jan 2026
EPS actual
-29.26 (0.0%)
estimate -29.26
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
14 Nov 2025
EPS actual
-35.84 (-15.3%)
estimate -31.08
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
W. Marc Hertz
Employees
3
IPO date
24 Apr 2023
ISIN
US3622AW5029
Website
gribio.com

Frequently asked questions

When does GRI Bio, Inc. (GRI) next report earnings?

GRI Bio, Inc. (GRI) is scheduled to report earnings on November 18, 2026.

What was GRI Bio, Inc.'s most recent earnings date?

GRI Bio, Inc. (GRI) last reported earnings on August 14, 2026.

Where is GRI Bio, Inc. stock listed?

GRI Bio, Inc. (GRI) is listed on Nasdaq.